Publications

Export 24 results:
Auteur Title Type [ Année(Asc)]
Filtres: Mot-clé is Biomarkers  [Enlever les filtres]
2016
Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C et al..  2016.  Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.. J Alzheimers Dis. 52(1):51-64.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Chaput J-P, Gray CE, Poitras VJ, Carson V, Gruber R, Olds T, Weiss SK, Gorber SConnor, Kho ME, Sampson M et al..  2016.  Systematic review of the relationships between sleep duration and health indicators in school-aged children and youth.. Appl Physiol Nutr Metab. 41(6 Suppl 3):S266-82.
Leh SE, Kälin AM, Schroeder C, Park MTae M, M Chakravarty M, Freund P, Gietl AF, Riese F, Kollias S, Hock C et al..  2016.  Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.. J Alzheimers Dis. 49(1):237-49.
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT.  2016.  Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 12(1):60-4.
2014
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JLuis, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R et al..  2014.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.. Lancet Neurol. 13(6):614-29.
Godlewska BR, Yip SW, Near J, Goodwin GM, Cowen PJ.  2014.  Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 231(2):327-32.
Au B, Smith KJ, Gariépy G, Schmitz N.  2014.  C-reactive protein, depressive symptoms, and risk of diabetes: results from the English Longitudinal Study of Ageing (ELSA).. J Psychosom Res. 77(3):180-6.
Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M.  2014.  Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.. J Intern Med. 275(3):304-16.
Ouimet MClaude, Brown TG, Guo F, Klauer SG, Simons-Morton BG, Fang Y, Lee SE, Gianoulakis C, Dingus TA.  2014.  Higher crash and near-crash rates in teenaged drivers with lower cortisol response: an 18-month longitudinal, naturalistic study.. JAMA Pediatr. 168(6):517-22.
Leuzy A, Zimmer ERigon, Bhat V, Rosa-Neto P, Gauthier S.  2014.  Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.. Int Psychogeriatr. 26(5):703-7.
Amoako-Tuffour Y, Jones ML, Shalabi N, Labbe A, Vengallatore S, Prakash S.  2014.  Ingestible gastrointestinal sampling devices: state-of-the-art and future directions.. Crit Rev Biomed Eng. 42(1):1-15.
Richard-Devantoy S, Berlim M, Jollant F.  2014.  A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders.. Psychol Med. 44(8):1663-73.
Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L.  2014.  Mild cognitive impairment: a concept in evolution.. J Intern Med. 275(3):214-28.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.

McGill Logo

CIUSSS ouest montreal logo

 



  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre